Page 1677 - Cote clinical veterinary advisor dogs and cats 4th
P. 1677

842   Pulmonary Thromboembolism


           •  Address infection, parasitism, granuloma or   neoplasm, one that involves an entire lobe,   •  Eosinophilic  bronchopneumopathy  can
            other cause as needed (e.g., blastomycosis    squamous cell carcinoma histologically, or   closely mimic metastatic lung cancer and
  VetBooks.ir  Possible Complications         •  Cats  with  primary  lung  tumors:  median   •  In  this  author’s  experience,  cats  with
            [p. 121], eosinophilic bronchopneumopathy
                                                                                   should be considered in young dogs, espe-
                                                  nodal metastasis (1-2 months).
                                                                                   cially in predisposed breeds.
            [p. 298])
                                                survival time of 4 months after lobectomy.
                                                enlarged tracheobronchial lymph nodes:
                                                                                   signs, have more advanced disease at the time
           •  Hypertrophic osteopathy typically resolves   Cats with poorly differentiated tumors or   pulmonary metastases tend to show overt
            with removal of pulmonary disease.  median of 2 months                 of presentation, and have markedly shorter
           •  Digital or ocular metastasis (cats), particularly   •  The use of chemotherapy has not been well   survival times compared with dogs.
            with angioinvasive neoplasms        studied in the management of pulmonary
           •  Pneumothorax: ruptured cyst or tumor  carcinoma, but carboplatin, cisplatin (dogs   Technician Tips
                                                only), doxorubicin, and vinorelbine may   •  If pleural effusion is present, both dorsoven-
           Recommended Monitoring               have efficacy  in its treatment,  particularly   tral and ventrodorsal thoracic radiographic
           •  Monthly to quarterly radiographs to assess   when surgery is not possible or lymphatic   views can be useful. Ask the clinician about
            for  recurrence,  progression,  or  changes   metastasis are identified.  her/his preferences.
            (cavitation is not uncommon but is often                             •  Vinorelbine  is  a  vinca  alkaloid  drug  that
            misinterpreted as abscess/infection)   PEARLS & CONSIDERATIONS         is used in the management of pulmonary
           •  As  required  per  protocol  for  chemo-                             tumors. It is imperative that with absolute
            therapy patients (e.g., CBC), quality-of-life   Comments               certainty vinorelbine (not vincristine or
            assessments                       •  Metastatic neoplasia is much more common   vinblastine) is drawn up for administration
                                                than primary pulmonary neoplasia.  because the dosage for vinorelbine is 5 to 10
            PROGNOSIS & OUTCOME               •  One-half of patients with newly diagnosed   times higher than for the other two drugs.
                                                pulmonary neoplasia are deemed inoperable   Inadvertent substitution of the latter two
           Guarded and extremely variable (median   because regional or systemic extension is   drugs for the former would likely prove fatal.
           survival times in parentheses):      identified at presentation.
           •  Dogs with primary lung tumors   •  Pulmonary osteomas are benign mineraliza-  SUGGESTED READING
            ○   50% of dogs without clinical signs and   tions often identified incidentally on the   Rebhun RB, et al: Tumors of the respiratory system
              having peripheral, solitary, small (<5 cm),   radiographs of older dogs. The diagnosis   and pulmonary neoplasia. In Withrow SJ, et al,
              well-differentiated, low-grade pulmonary   of osteoma versus metastasis can be made   editors:  Withrow  and  MacEwen’s  Small  animal
              adenocarcinomas without lymph node   empirically based on size and relative opacity.   clinical oncology, ed 5, St. Louis, 2013, Saunders,
              metastasis or pleural effusion have median   The limit of detection for soft-tissue lesions in   pp 453-459.
              survival time > 1 year (12-20 months).  the pulmonary parenchyma is considered to   AUTHOR: Carlos O. Rodriguez, Jr., DVM, PhD,
            ○   In contrast, median survival time is shorter   be 5-10 mm. Because osteomas have mineral   DACVIM
              (8 months) for patients with clinical signs   or bone density, they can be identified in the   EDITOR: Kenneth M. Rassnick, DVM, DACVIM
              referable to the pulmonary nodule/mass or   2-5 mm range.
                                         3
              with a large solitary (>5 cm or 100 cm )





            Pulmonary Thromboembolism                                                              Client Education
                                                                                                         Sheet


            BASIC INFORMATION                 •  Disseminated intravascular coagulation  •  Occasionally,  signs  of  right-sided  heart
                                              •  Immune-mediated hemolytic anemia  failure (abdominal distention, exercise
           Definition                         •  Protein-losing nephropathy/enteropathy  intolerance)
           Pulmonary  thromboembolism  (PTE)  is  the   •  Central catheters     •  Uncommonly, cough or hemoptysis
           occlusion of a pulmonary artery or arteriole   •  Vasculitis          •  Nonspecific  signs  (lethargy,  anorexia/
           by a thrombus that forms in the systemic   •  Pancreatitis              inappetence, weight loss, collapse)
           venous  system/right  heart  (embolism)  or   •  Cardiac disease
           in the pulmonary arterial system (in situ    •  Surgical  procedures,  especially  total  hip   PHYSICAL EXAM FINDINGS
           thrombus).                           replacement                      Depends on degree of vascular occlusion and
                                              •  Trauma                          hypoxemia.
           Epidemiology                       •  Glucocorticoid administration   •  Tachypnea/dyspnea
           SPECIES, AGE, SEX                                                     •  Pulmonary auscultation is often normal, but
           •  Dogs: any age; median of 11 years  ASSOCIATED DISORDERS              increased bronchovesicular sounds/crackles
           •  Cats: any age; median of 7 years  Hypoxemia, right-sided congestive heart failure,   might be heard.
                                              pulmonary hypertension (PH)        •  Cyanosis (if severe hypoxemia)
           RISK FACTORS                                                          •  Tachycardia and weak pulses
           Many predisposing conditions for PTE have   Clinical Presentation     •  Findings reflecting the predisposing condition
           been identified, and treatment of the underlying   HISTORY, CHIEF COMPLAINT  (e.g., pallor if hemolytic anemia)
           cause is the cornerstone of management.  •  Acute-onset  dyspnea/tachypnea;  may  be   •  Occasionally,  findings  are  consistent  with
           •  Neoplasia                         mild or progressive when PTE is small or     right-sided congestive heart failure (jugular
           •  Heartworm disease                 gradual, respectively              venous distention/pulsation, ascites).
           •  Sepsis                          •  Signs  of  the  underlying  disorder  may   •  Right apical murmur or split-second heart
           •  Hyperadrenocorticism              predominate.                       sound is possible with PH (p. 838).

                                                     www.ExpertConsult.com
   1672   1673   1674   1675   1676   1677   1678   1679   1680   1681   1682